$MNKD
MANNKIND CORP

2013 Q1 Form 10-K Financial Statement

#000119312513112693 Filed on March 18, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2011 Q4 2011 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.00M $10.40M $9.600M
YoY Change 2.04% 31.65% -13.51%
% of Gross Profit
Research & Development $26.40M $20.50M $23.10M
YoY Change 9.28% -15.29% -26.43%
% of Gross Profit
Depreciation & Amortization $2.990M $3.810M $4.080M
YoY Change -10.93% -13.41% -5.34%
% of Gross Profit
Operating Expenses $36.44M $31.00M $32.80M
YoY Change 7.38% -3.43% -22.82%
Operating Profit -$36.44M
YoY Change 7.38%
Interest Expense -$4.600M -$5.900M -$5.700M
YoY Change -17.86% 5.36% 21.28%
% of Operating Profit
Other Income/Expense, Net $23.00K $100.0K $100.0K
YoY Change -98.34% -116.67% -94.74%
Pretax Income -$40.97M -$36.40M -$38.40M
YoY Change 7.31% -4.96% -15.23%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$40.97M -$36.40M -$38.40M
YoY Change 7.31% -4.97% -15.23%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$732.1K -$1.486M -$1.574M
COMMON SHARES
Basic Shares Outstanding 289.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q1 2011 Q4 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $28.00M $2.700M $23.30M
YoY Change -50.62% -96.16% -76.22%
Cash & Equivalents $28.01M $2.681M $22.80M
Short-Term Investments $25.70M $600.0K $500.0K
Other Short-Term Assets $3.800M $3.100M $3.000M
YoY Change 26.67% 10.71% -9.09%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $32.29M $5.821M $27.00M
YoY Change -45.92% -92.13% -73.53%
LONG-TERM ASSETS
Property, Plant & Equipment $182.3M $193.0M $196.4M
YoY Change -4.51% -4.63% -2.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $230.0K $230.0K $600.0K
YoY Change -71.25% -74.44% -33.33%
Total Long-Term Assets $182.9M $193.7M $197.0M
YoY Change -4.58% -4.71% -3.0%
TOTAL ASSETS
Total Short-Term Assets $32.29M $5.821M $27.00M
Total Long-Term Assets $182.9M $193.7M $197.0M
Total Assets $215.2M $199.6M $224.0M
YoY Change -14.4% -28.04% -26.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.604M $4.624M $1.600M
YoY Change 33.48% 40.12% -75.0%
Accrued Expenses $26.38M $20.74M $14.50M
YoY Change -16.79% 40.11% -9.94%
Deferred Revenue
YoY Change
Short-Term Debt $119.6M $0.00 $0.00
YoY Change
Long-Term Debt Due $114.6M $0.00
YoY Change
Total Short-Term Liabilities $264.2M $25.36M $17.30M
YoY Change 668.06% 40.11% -32.42%
LONG-TERM LIABILITIES
Long-Term Debt $97.80M $487.8M $487.5M
YoY Change -80.22% 9.69% 5.75%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $97.80M $487.8M $487.5M
YoY Change -80.22% 9.69% 5.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $264.2M $25.36M $17.30M
Total Long-Term Liabilities $97.80M $487.8M $487.5M
Total Liabilities $362.0M $513.2M $504.8M
YoY Change -31.54% 10.89% 3.74%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.999B $1.622B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$146.8M -$313.7M -$280.8M
YoY Change
Total Liabilities & Shareholders Equity $215.2M $199.6M $224.0M
YoY Change -14.4% -28.04% -26.58%

Cashflow Statement

Concept 2013 Q1 2011 Q4 2011 Q3
OPERATING ACTIVITIES
Net Income -$40.97M -$36.40M -$38.40M
YoY Change 7.31% -4.97% -15.23%
Depreciation, Depletion And Amortization $2.990M $3.810M $4.080M
YoY Change -10.93% -13.41% -5.34%
Cash From Operating Activities -$32.03M -$20.36M -$36.03M
YoY Change -1.41% -47.75% 3.39%
INVESTING ACTIVITIES
Capital Expenditures $1.459M -$160.0K -$590.0K
YoY Change 351.7% -95.93% -62.18%
Acquisitions
YoY Change
Other Investing Activities $0.00 $30.00K $0.00
YoY Change -100.0% -100.72% -100.0%
Cash From Investing Activities -$1.459M -$130.0K -$590.0K
YoY Change 401.37% -98.4% -234.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -349.0K 370.0K 34.65M
YoY Change -100.4% -97.57% -66.67%
NET CHANGE
Cash From Operating Activities -32.03M -20.36M -36.03M
Cash From Investing Activities -1.459M -130.0K -590.0K
Cash From Financing Activities -349.0K 370.0K 34.65M
Net Change In Cash -33.84M -20.12M -1.970M
YoY Change -163.04% -36.85% -102.83%
FREE CASH FLOW
Cash From Operating Activities -$32.03M -$20.36M -$36.03M
Capital Expenditures $1.459M -$160.0K -$590.0K
Free Cash Flow -$33.49M -$20.20M -$35.44M
YoY Change 2.06% -42.35% 6.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 mnkd Issuance Of Common Stock And Warrants Gross Value
IssuanceOfCommonStockAndWarrantsGrossValue
86300000
CY2012Q1 mnkd Restricted Stock Agreed To Be Purchased By Lender
RestrictedStockAgreedToBePurchasedByLender
77200000
CY2012Q1 mnkd Units Sold Under Public Offer Underwritten
UnitsSoldUnderPublicOfferUnderwritten
35937500 shares
CY2012Q1 mnkd Units Sold Under Public Offer Underwritten Composition Description
UnitsSoldUnderPublicOfferUnderwrittenCompositionDescription
Each unit consisting of one share of common stock and a warrant to purchase 0.6 of a share of common stock
CY2012Q1 mnkd Units Sold Warrant Portion Convertible Into Common Stock
UnitsSoldWarrantPortionConvertibleIntoCommonStock
0.6
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2012Q2 mnkd Fair Value Input Discount For Lack Of Marketability
FairValueInputDiscountForLackOfMarketability
0.0042 pure
CY2012Q2 mnkd Fair Value Of Units Issued
FairValueOfUnitsIssued
1.69
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
289350125 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31250000 shares
CY2012Q2 dei Entity Public Float
EntityPublicFloat
264556791
CY2004Q3 mnkd Operating Loss Carryforwards Subject To Limitation
OperatingLossCarryforwardsSubjectToLimitation
216000000
CY2012Q3 mnkd Fair Value Assumption Expected Volatility Rate
FairValueAssumptionExpectedVolatilityRate
0.54 pure
CY2012Q3 mnkd Fair Value Assumption Risk Free Interest Rate
FairValueAssumptionRiskFreeInterestRate
0.001 pure
CY2012Q3 mnkd Loss Contingency Settlement Agreement Stock Consideration
LossContingencySettlementAgreementStockConsideration
8600000
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
2.60
CY2012Q4 mnkd Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
125400000
CY1992Q1 us-gaap Stockholders Equity
StockholdersEquity
-11000
CY1993Q1 us-gaap Stockholders Equity
StockholdersEquity
-278000
CY1994Q1 us-gaap Stockholders Equity
StockholdersEquity
-908000
CY1994Q4 us-gaap Stockholders Equity
StockholdersEquity
-707000
CY1995Q4 us-gaap Stockholders Equity
StockholdersEquity
-3108000
CY1996Q4 us-gaap Stockholders Equity
StockholdersEquity
-5481000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
4.49
CY2010Q4 mnkd Shares Reserved For Employee Stock Purchase Plan
SharesReservedForEmployeeStockPurchasePlan
700000 shares
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
2827000
CY2011Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3140000
CY1997Q4 us-gaap Stockholders Equity
StockholdersEquity
-7368000
CY1998Q4 us-gaap Stockholders Equity
StockholdersEquity
3404000
CY1999Q4 us-gaap Stockholders Equity
StockholdersEquity
-746000
CY2000Q4 us-gaap Stockholders Equity
StockholdersEquity
31890000
CY2001Q4 us-gaap Goodwill
Goodwill
151400000
CY2001Q4 us-gaap Stockholders Equity
StockholdersEquity
235018000
CY2002Q4 us-gaap Stockholders Equity
StockholdersEquity
90773000
CY2003Q4 us-gaap Stockholders Equity
StockholdersEquity
111577000
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
150363000
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
206977000
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
383487000
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
364100000
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
86734000
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-59221000
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30019000
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-185532000
CY2010Q4 us-gaap Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
9000000 shares
CY2010Q4 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2010Q4 us-gaap Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
25500000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66061000
CY2010Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2010Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
385000
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
284793000
CY2011Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2011Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
473000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1620535000
CY2011Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
689412000
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000
CY2011Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
59848000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-313652000
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1094000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8997000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
168
CY2011Q4 us-gaap Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
9000000 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131522945 shares
CY2011Q4 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2011Q4 mnkd Shares Reserved For Employee Stock Purchase Plan
SharesReservedForEmployeeStockPurchasePlan
700000 shares
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
2922000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4520000
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
27964000
CY2011Q4 us-gaap Deferred Tax Assets Gross Current
DeferredTaxAssetsGrossCurrent
718200000
CY2011Q4 us-gaap Liabilities
Liabilities
513205000
CY2011Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
277203000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4624000
CY2011Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
557427000
CY2011Q4 us-gaap Notional Amount Of Foreign Currency Cash Flow Hedge Derivatives
NotionalAmountOfForeignCurrencyCashFlowHedgeDerivatives
0
CY2011Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
8906000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
4.47
CY2011Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
1935546000
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2011Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2700000
CY2011Q4 us-gaap Assets
Assets
199553000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.67
CY2011Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
210642000
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
199553000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2681000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131522945 shares
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
44000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
4137688 shares
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20736000
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25360000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10082351 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
1315000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Interest Payable Current
InterestPayableCurrent
8262000
CY2011Q4 us-gaap Assets Current
AssetsCurrent
5821000
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2011Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
689412000
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
91764000
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
193029000
CY2011Q4 mnkd Deferred Tax Liabilities Gross
DeferredTaxLiabilitiesGross
28800000
CY2011Q4 mnkd Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
32440000
CY2011Q4 mnkd Accrued Interest Of Related Party Debt
AccruedInterestOfRelatedPartyDebt
5900000
CY2011Q4 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
2383000
CY2011Q4 mnkd Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
45000000
CY2011Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2011Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
609000
CY2011Q4 mnkd Related Party Transaction Principal Amount Outstanding Under Loan Arrangement
RelatedPartyTransactionPrincipalAmountOutstandingUnderLoanArrangement
277203000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
21000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
285210000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
30928000
CY2012Q4 us-gaap Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
9000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
286035082 shares
CY2012Q4 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2012Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
119600000
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6630516 shares
CY2012Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
313000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1991379000
CY2012Q4 us-gaap Debt Instrument Basis Spread On Variable Rate
DebtInstrumentBasisSpreadOnVariableRate
0.05 pure
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
750151000
CY2012Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
450000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
230000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7199768 shares
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
65315000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-110679000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1297000
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
602
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10074000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.26
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4867
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
77400000
CY2012Q4 us-gaap Deferred Tax Assets Gross Current
DeferredTaxAssetsGrossCurrent
784600000
CY2012Q4 us-gaap Liabilities
Liabilities
361993000
CY2012Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
119635000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4555000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
609471000
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
10025000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.73
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
2104912000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
61800000
CY2012Q4 us-gaap Assets
Assets
251314000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.46
CY2012Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
97583000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
251314000
CY2012Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
125400000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
4867
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61840000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
286035082 shares
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1100000000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
17546663 shares
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
3761031 shares
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
25777000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
144775000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18674539 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2860000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
4533000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
66810000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1600000000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
750151000
CY2012Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
114443000
CY2012Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
3878000
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
101249000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
183961000
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.53
CY2012Q4 mnkd Deferred Tax Liabilities Gross
DeferredTaxLiabilitiesGross
34400000
CY2012Q4 mnkd Weighted Average Grant Date Fair Value Of Restricted Stock Units Expected To Vest
WeightedAverageGrantDateFairValueOfRestrictedStockUnitsExpectedToVest
3.74
CY2012Q4 mnkd Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
31490000
CY2012Q4 mnkd Share Based Compensation Arrangement Restricted Stock Units Number Of Units Expected To Vest
ShareBasedCompensationArrangementRestrictedStockUnitsNumberOfUnitsExpectedToVest
3254819 shares
CY2012Q4 mnkd Restricted Stock Awards Vesting Rate
RestrictedStockAwardsVestingRate
0.25 pure
CY2012Q4 mnkd Accrued Interest Of Related Party Debt
AccruedInterestOfRelatedPartyDebt
2200000
CY2012Q4 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
5995000
CY2012Q4 mnkd Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
12750000
CY2012Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2012Q4 mnkd Derivatives Fair Value Liability Shares Issuable To Lender
DerivativesFairValueLiabilitySharesIssuableToLender
16500000 shares
CY2012Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
289000
CY2012Q4 mnkd Fair Value Of Units Issued
FairValueOfUnitsIssued
2.40
CY2012Q4 mnkd Loss Contingency Settlement Agreement Stock Consideration
LossContingencySettlementAgreementStockConsideration
8600000
CY2012Q4 mnkd Increase Decrease In Fair Value Recognized In Other Income
IncreaseDecreaseInFairValueRecognizedInOtherIncome
12000000
CY2012Q4 mnkd Related Party Transaction Principal Amount Outstanding Under Loan Arrangement
RelatedPartyTransactionPrincipalAmountOutstandingUnderLoanArrangement
119635000
CY2012Q4 mnkd Shares Reserved For Employee Stock Purchase Plan
SharesReservedForEmployeeStockPurchasePlan
700000 shares
CY2012Q4 mnkd Escrow Deposit Of Common Stock
EscrowDepositOfCommonStock
2777778 shares
CY2012Q4 mnkd Common Stock Issued To Plaintiff Attorneys
CommonStockIssuedToPlaintiffAttorneys
225000 shares
CY2012Q4 mnkd Loss Contingency Settlement Agreement Stock Consideration Fair Value
LossContingencySettlementAgreementStockConsiderationFairValue
6492056
CY2011Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1177300 shares
CY2012Q4 mnkd Additional Commons Stock Shares Issued During Period
AdditionalCommonsStockSharesIssuedDuringPeriod
6000000 shares
CY2011Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8200000
CY2011Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1467500 shares
CY2011Q1 mnkd Share Based Compensation Arrangement By Share Based Payment Award Annual Vesting Percentage
ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualVestingPercentage
0.50 pure
mnkd Loss Contingency Settlement Agreement Stock Issuable
LossContingencySettlementAgreementStockIssuable
901000 shares
mnkd Stock Price Used To Forecast Future Liability
StockPriceUsedToForecastFutureLiability
1.00
CY2009Q2 mnkd Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Increase In Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseInGrant
5000000 shares
CY2012Q2 us-gaap Forward Contract Indexed To Issuers Equity Shares
ForwardContractIndexedToIssuersEquityShares
250000000 shares
CY2012Q4 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0011 pure
CY2012Q4 us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.023 pure
CY2001Q4 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
19700000
CY2012Q4 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0000 pure
CY2012Q4 us-gaap Fair Value Inputs Discount Rate
FairValueInputsDiscountRate
0.015 pure
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1805000
us-gaap Net Income Loss
NetIncomeLoss
-2004000
mnkd Notes Receivable From Stockholders Collection Of Stock Subscription
NotesReceivableFromStockholdersCollectionOfStockSubscription
400000
CY2011Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
257 Employee
CY2011Q1 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.41 pure
CY2011Q1 us-gaap Restructuring Charges
RestructuringCharges
6700000
CY2004Q1 mnkd Percentage Of Common Stock Shares Outstanding
PercentageOfCommonStockSharesOutstanding
0.01 pure
CY2011Q2 mnkd Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Increase In Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseInGrant
6000000 shares
CY2012Q2 us-gaap Forward Contract Indexed To Issuers Equity Shares
ForwardContractIndexedToIssuersEquityShares
250000000 shares
CY2004Q3 mnkd Net Operating Loss Carryforward Annual Limitation
NetOperatingLossCarryforwardAnnualLimitation
13000000
CY2007Q4 mnkd Loan Agreement With Related Party
LoanAgreementWithRelatedParty
350000000
CY2012Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
92000000
CY2012Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
40000000 shares
CY2012Q4 mnkd Number Of Shares Of Common Stock In Each Unit
NumberOfSharesOfCommonStockInEachUnit
1 shares
CY2012Q4 mnkd Common Stock Issuable Upon Exercise Of Warrants Conversion Ratio
CommonStockIssuableUponExerciseOfWarrantsConversionRatio
0.75 pure
CY2012Q4 mnkd Warrant Expiration Month Year
WarrantExpirationMonthYear
2013-10
CY2012Q4 mnkd Net Proceeds From Public Offering
NetProceedsFromPublicOffering
86300000
CY2012Q4 mnkd Additional Purchase Of Common Stock
AdditionalPurchaseOfCommonStock
4500000 shares
CY2012Q4 mnkd Common Stock Purchase
CommonStockPurchase
30000000 shares
CY2002Q4 mnkd Headcount Reduction Percentage
HeadcountReductionPercentage
0.50 pure
CY2009Q4 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-12800000
CY2012Q4 us-gaap Debt Instrument Description Of Variable Rate Basis
DebtInstrumentDescriptionOfVariableRateBasis
annual interest rate on all outstanding principal to the one-year London Interbank Offered Rate (LIBOR) on December 31, 2012 plus 5%, effective January 1, 2013
CY2012Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2014-01-01
CY2012Q4 us-gaap Forward Contract Indexed To Issuers Equity Shares
ForwardContractIndexedToIssuersEquityShares
350000000 shares
CY1993 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
888000
CY1993 us-gaap Net Income Loss
NetIncomeLoss
-1175000
CY1993 mnkd Adjustments To Additional Paid In Capital Contribution
AdjustmentsToAdditionalPaidInCapitalContribution
20000
CY1994 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
526000
CY1994 us-gaap Net Income Loss
NetIncomeLoss
-1156000
CY1995 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
384000
CY1995 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
22000
CY1995 us-gaap Net Income Loss
NetIncomeLoss
-2815000
CY1995 mnkd Stock Issued During Period Value Services
StockIssuedDuringPeriodValueServices
8000
CY1997 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2000
CY1997 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
196000
CY1997 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
60000
CY1997 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
135000
CY1997 us-gaap Net Income Loss
NetIncomeLoss
-2280000
CY1998 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
150000
CY1998 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12726000
CY1998 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1202000
CY1998 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25000
CY1998 us-gaap Net Income Loss
NetIncomeLoss
-3331000
CY1999 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
534000
CY1999 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
995000
CY1999 us-gaap Net Income Loss
NetIncomeLoss
-5679000
CY2001 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1565000
CY2001 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
239000
CY2001 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
78030000
CY2001 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000
CY2001 us-gaap Net Income Loss
NetIncomeLoss
-48245000
CY2001 mnkd Adjustments To Additional Paid In Capital Cash Received From Common Stock
AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock
3900000
CY2001 mnkd Adjustments To Additional Paid In Capital Merger
AdjustmentsToAdditionalPaidInCapitalMerger
171154000
CY2001 mnkd Adjustments To Additional Paid In Capital Put Option Issue
AdjustmentsToAdditionalPaidInCapitalPutOptionIssue
2949000
CY2001 mnkd Notes Receivable From Stockholders Accrued Interest On Notes
NotesReceivableFromStockholdersAccruedInterestOnNotes
189000
CY2001 mnkd Notes Receivable From Stockholders Payments
NotesReceivableFromStockholdersPayments
28000
CY2001 mnkd Stock Issued During Period Value Services
StockIssuedDuringPeriodValueServices
60000
CY2002 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
268000
CY2002 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
251000
CY2002 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
58815000
CY2002 us-gaap Net Income Loss
NetIncomeLoss
-206265000
CY2002 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
151400000
CY2002 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
84000
CY2002 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1421000
CY2002 mnkd Adjustments To Additional Paid In Capital Cash Received From Common Stock
AdjustmentsToAdditionalPaidInCapitalCashReceivedFromCommonStock
98000
CY2002 mnkd Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Deemed Dividend
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend
1421000
CY2002 mnkd Adjustments To Additional Paid In Capital Put Option Redemption
AdjustmentsToAdditionalPaidInCapitalPutOptionRedemption
1921000
CY2002 mnkd Notes Receivable From Stockholders Accrued Interest On Notes
NotesReceivableFromStockholdersAccruedInterestOnNotes
229000
CY2002 mnkd Notes Receivable From Stockholders Payments
NotesReceivableFromStockholdersPayments
1314000
CY2003 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4501000
CY2003 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
253000
CY2003 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000000
CY2003 us-gaap Net Income Loss
NetIncomeLoss
-65879000
CY2003 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1017000
CY2003 mnkd Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Deemed Dividend
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend
1017000
CY2003 mnkd Adjustments To Additional Paid In Capital Non Cash Compensation
AdjustmentsToAdditionalPaidInCapitalNonCashCompensation
70000
CY2003 mnkd Adjustments To Additional Paid In Capital Put Option Sales
AdjustmentsToAdditionalPaidInCapitalPutOptionSales
623000
CY2003 mnkd Notes Receivable From Stockholders Accrued Interest On Notes
NotesReceivableFromStockholdersAccruedInterestOnNotes
105000
CY2003 mnkd Stock Issued During Period Value Cash
StockIssuedDuringPeriodValueCash
31847000
CY2005 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-1828000
CY2005 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
495000
CY2005 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
170234000
CY2005 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1951000
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-114338000
CY2005 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-145000
CY2005 mnkd Stock Issued During Period Value Exchange Of Warrants
StockIssuedDuringPeriodValueExchangeOfWarrants
245000
CY2006 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14667000
CY2006 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
981000
CY2006 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
384670000
CY2006 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2312000
CY2006 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-340000
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-230548000
CY2006 mnkd Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
2694000
CY2006 mnkd Stock Issued During Period Value Research Agreement
StockIssuedDuringPeriodValueResearchAgreement
2074000
CY2007 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17522000
CY2007 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1065000
CY2007 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
249750000
CY2007 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4923000
CY2007 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-524000
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-293190000
CY2007 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
123000
CY2007 mnkd Stock Issued During Period Value Research Agreement
StockIssuedDuringPeriodValueResearchAgreement
944000
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20219000
CY2009 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1400000
CY2009 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
59724000
CY2009 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
383000
CY2009 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
5000
CY2009 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-7001000
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-220104000
CY2009 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-581000
CY2010 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
6000
CY2010 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4287000
CY2010 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y1M6D
CY2010 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-725000
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13580000
CY2010 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
924000
CY2010 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-170205000
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
36042000
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1600000
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
-152498000
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2010 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16500000
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
13580000
CY2010 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.050 pure
CY2010 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2000000
CY2010 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
112279000
CY2010 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.50
CY2010 us-gaap Depreciation And Amortization
DepreciationAndAmortization
17324000
CY2010 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2010 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
87000000
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-148654000
CY2010 us-gaap Unrealized Loss On Foreign Currency Derivatives Before Tax
UnrealizedLossOnForeignCurrencyDerivativesBeforeTax
200000
CY2010 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10249000
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11720000
CY2010 us-gaap Investment Income Interest
InvestmentIncomeInterest
40000
CY2010 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1605000
CY2010 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
1742000
CY2010 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
pure
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
11400000
CY2010 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14335000
CY2010 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9542000
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40312000
CY2010 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-267000
CY2010 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
16681000
CY2010 us-gaap Unrealized Gain On Foreign Currency Derivatives Before Tax
UnrealizedGainOnForeignCurrencyDerivativesBeforeTax
1600000
CY2010 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-823000
CY2010 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
287597 shares
CY2010 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
924000
CY2010 us-gaap Sales Revenue Net
SalesRevenueNet
93000
CY2010 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-170560000
CY2010 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6000
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
196416000
CY2010 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
752000
CY2010 us-gaap Interest Expense Debt
InterestExpenseDebt
7128000
CY2010 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
4178000
CY2010 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-644000
CY2010 us-gaap Operating Expenses
OperatingExpenses
152591000
CY2010 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1200000
CY2010 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2010 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
56500000
CY2010 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-7554000
CY2010 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.300 pure
CY2010 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13580000
CY2010 us-gaap Interest Paid
InterestPaid
13662000
CY2010 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3392000
CY2010 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30858590 shares
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-170560000
CY2010 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
95783000
CY2010 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-170560000
CY2010 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
361000
CY2010 us-gaap Interest Expense
InterestExpense
17400000
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.06
CY2010 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
361000
CY2010 mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
17025000
CY2010 mnkd Potential Dilutive Securities That Could Be Included In Computation Of Earnings Per Share Amount
PotentialDilutiveSecuritiesThatCouldBeIncludedInComputationOfEarningsPerShareAmount
30858590 shares
CY2010 mnkd Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value Amount
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValueAmount
10500000
CY2010 mnkd Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
pure
CY2010 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
113672000 shares
CY2010 mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
16681000
CY2010 mnkd Payment Of Employment Taxes Related To Vested Restricted Stock Units
PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits
3392000
CY2010 mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
1115000
CY2010 mnkd Stock Issued During Period Value Share Lending Agreement
StockIssuedDuringPeriodValueShareLendingAgreement
161000
CY2010 mnkd Payments For Use Of Aircrafts
PaymentsForUseOfAircrafts
230000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
443000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-140539000
CY2011 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3000
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2672000
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1541000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11204000
CY2011 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
625000
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-160834000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14600000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
11204000
CY2011 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.050 pure
CY2011 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
3828000
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
93000
CY2011 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
99959000
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.32
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
15912000
CY2011 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2011 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
53000000
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-123837000
CY2011 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10883000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2937000
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
18000
CY2011 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
769000
CY2011 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
250000
CY2011 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
pure
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1600000
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9540000
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6858000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-63380000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40630000
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-87000
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
11116000
CY2011 us-gaap Unrealized Gain On Foreign Currency Derivatives Before Tax
UnrealizedGainOnForeignCurrencyDerivativesBeforeTax
1300000
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-224000
CY2011 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1300000
CY2011 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
282816 shares
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
628000
CY2011 us-gaap Sales Revenue Net
SalesRevenueNet
50000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-160804000
CY2011 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
63394000
CY2011 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
777000
CY2011 us-gaap Interest Expense Debt
InterestExpenseDebt
10941000
CY2011 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
400000
CY2011 us-gaap Operating Expenses
OperatingExpenses
140589000
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
766000
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2011 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
57200000
CY2011 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6045000
CY2011 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.300 pure
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11204000
CY2011 us-gaap Interest Paid
InterestPaid
17248000
CY2011 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-543000
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34048852 shares
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-160804000
CY2011 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-160804000
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-27000
CY2011 us-gaap Interest Expense
InterestExpense
21800000
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.04
CY2011 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-27000
CY2011 mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
10941000
CY2011 mnkd Restructuring Charges Net Of Tax
RestructuringChargesNetOfTax
6300000
CY2011 mnkd Potential Dilutive Securities That Could Be Included In Computation Of Earnings Per Share Amount
PotentialDilutiveSecuritiesThatCouldBeIncludedInComputationOfEarningsPerShareAmount
34048852 shares
CY2011 mnkd Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value Amount
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValueAmount
1700000
CY2011 mnkd Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
pure
CY2011 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
121817000 shares
CY2011 mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
11116000
CY2011 mnkd Nominal Lending Fee
NominalLendingFee
0.01
CY2011 mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
4000
CY2011 mnkd Payment Of Employment Taxes Related To Vested Restricted Stock Units
PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits
547000
CY2011 mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
830000
CY2011 mnkd Payments For Use Of Aircrafts
PaymentsForUseOfAircrafts
111000
CY1996 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
126000
CY1996 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
59000
CY1996 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000
CY1996 us-gaap Net Income Loss
NetIncomeLoss
-2570000
CY2000 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9609000
CY2000 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
149000
CY2000 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
31633000
CY2000 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1074000
CY2000 us-gaap Net Income Loss
NetIncomeLoss
-24661000
CY2000 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-993000
CY2000 mnkd Stock Issued During Period Value
StockIssuedDuringPeriodValue
15000000
CY2000 mnkd Adjustments To Additional Paid In Capital Amount In Excess Of Redemption Obligation
AdjustmentsToAdditionalPaidInCapitalAmountInExcessOfRedemptionObligation
999000
CY2000 mnkd Notes Receivable From Stockholders Accrued Interest On Notes
NotesReceivableFromStockholdersAccruedInterestOnNotes
117000
CY2000 mnkd Notes Receivable From Stockholders Discount On Notes Below Market Rate
NotesReceivableFromStockholdersDiscountOnNotesBelowMarketRate
241000
CY2004 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6810000
CY2004 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
60000
CY2004 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
430000
CY2004 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
18153000
CY2004 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1079000
CY2004 us-gaap Net Income Loss
NetIncomeLoss
-75992000
CY2004 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
19822000
CY2004 mnkd Stock Issued During Period Value Initial Public Offering
StockIssuedDuringPeriodValueInitialPublicOffering
83176000
CY2004 mnkd Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
46000
CY2004 mnkd Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Deemed Dividend
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend
19822000
CY2004 mnkd Notes Receivable From Officers Repayment
NotesReceivableFromOfficersRepayment
3000
CY2004 mnkd Notes Receivable From Stockholders Accrued Interest On Notes
NotesReceivableFromStockholdersAccruedInterestOnNotes
107000
CY2004 mnkd Stock Issued During Period Value Conversion Of Convertible Securities Series A
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesSeriesA
5248000
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24811000
CY2008 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
900000
CY2008 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-315000
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-303039000
CY2008 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-18000
CY2008 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
295000
CY2012 dei Trading Symbol
TradingSymbol
MNKD
CY2012 dei Entity Registrant Name
EntityRegistrantName
MANNKIND CORP
CY2012 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012 dei Amendment Flag
AmendmentFlag
false
CY2012 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2012 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2012 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012 dei Document Type
DocumentType
10-K
CY2012 dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0000899460
CY2012 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2012 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-146960000
CY2012 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2000
CY2012 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
14219000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
44000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y6M
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1191000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13292000
CY2012 us-gaap Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions
9200
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-169416000
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
15.17
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1371455 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13000000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
13292000
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.81
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.040 pure
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.96
CY2012 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
16000000
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
77000
CY2012 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
101522000
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.94
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3216 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
485065 shares
CY2012 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 2%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Concentration of Credit Risk</i> &#x2014; Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents consist primarily of interest-bearing accounts and are regularly monitored by management and held in high credit quality institutions.</font></p> </div>
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14402000
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2012 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
12750000
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-119860000
CY2012 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10491000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-560000
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
7000
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
862000
CY2012 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
4072000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1277572 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.86
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
3000000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
637000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
59159000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45473000
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
184537000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
4.25
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1545000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9795600 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.25
CY2012 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M18D
CY2012 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1400000
CY2012 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
300000
CY2012 us-gaap Operating Expenses
OperatingExpenses
146995000
CY2012 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
422260 shares
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
35000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-169774000
CY2012 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
179579000
CY2012 us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-48000
CY2012 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
571000
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
11139000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
715131 shares
CY2012 us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-117000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
675000
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350 pure
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
60700000
CY2012 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
15075000
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.310 pure
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13292000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2012 us-gaap Interest Paid
InterestPaid
9755000
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-906000
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
128324123 shares
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-169366000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-408000
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-169366000
CY2012 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 2%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2"><i>Financial Statement Estimates</i> &#x2014; The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201C;GAAP&#x201D;) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. The more significant estimates reflected in these accompanying financial statements involve assessing long-lived assets for impairment, accrued expenses, including clinical trial expenses, valuation of forward purchase contracts, valuation of stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities and any valuation allowance recorded against net deferred tax assets.</font></p> </div>
CY2012 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1237000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
470540 shares
CY2012 us-gaap Interest Expense
InterestExpense
21600000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.99
CY2012 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-48000
CY2012 mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
167735000
CY2012 mnkd Stock Issued During Period Value Initial Public Offering
StockIssuedDuringPeriodValueInitialPublicOffering
166864000
CY2012 mnkd Deposits To Litigation Escrow Account
DepositsToLitigationEscrowAccount
16000000
CY2012 mnkd Potential Dilutive Securities That Could Be Included In Computation Of Earnings Per Share Amount
PotentialDilutiveSecuritiesThatCouldBeIncludedInComputationOfEarningsPerShareAmount
128324123 shares
CY2012 mnkd Change In Fair Value Of Forward Exchange Rate Contracts
ChangeInFairValueOfForwardExchangeRateContracts
-1237000
CY2012 mnkd Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
80600000
CY2012 mnkd Value Of Restricted Stock Units Vested
ValueOfRestrictedStockUnitsVested
7500000
CY2012 mnkd Maturity Period Of Cash Equivalents
MaturityPeriodOfCashEquivalents
90 days or less at the time of purchase
CY2012 mnkd Research And Development Credits Expiration Year
ResearchAndDevelopmentCreditsExpirationYear
2033
CY2012 mnkd Stock Options Granted Vesting Rate
StockOptionsGrantedVestingRate
0.25 pure
CY2012 mnkd Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Intrinsic Value Amount
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodIntrinsicValueAmount
2900000
CY2012 mnkd Stock Issued During Period Value Issued Related To Legal Settlement
StockIssuedDuringPeriodValueIssuedRelatedToLegalSettlement
438000
CY2012 mnkd Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
pure
CY2012 mnkd Amortization Period Of Lease Hold Improvements
AmortizationPeriodOfLeaseHoldImprovements
P4Y
CY2012 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
180855000 shares
CY2012 mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
184537000
CY2012 mnkd Forward Purchase Contract Contribution To Additional Paid In Capital
ForwardPurchaseContractContributionToAdditionalPaidInCapital
29317000
CY2012 mnkd Loss Contingency Settlement Agreement Stock Issuable
LossContingencySettlementAgreementStockIssuable
3002778 shares
CY2012 mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-682000
CY2012 mnkd Payment Of Employment Taxes Related To Vested Restricted Stock Units
PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits
906000
CY2012 mnkd Percentage Of Credit Exchange Receivable
PercentageOfCreditExchangeReceivable
0.65 pure
CY2012 mnkd Reclassification Of Forward Purchase Contract To Additional Paid In Capital
ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital
28080000
CY2012 mnkd Related Party Transaction Prepayment Period
RelatedPartyTransactionPrepaymentPeriod
P90D
CY2012 mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-290000
CY2012 mnkd Payments For Use Of Aircrafts
PaymentsForUseOfAircrafts
200000
CY2012 mnkd Adjustments To Additional Paid In Capital Net Share Settlement Of Equity Awards
AdjustmentsToAdditionalPaidInCapitalNetShareSettlementOfEquityAwards
6056000
CY2012 mnkd Common Shares Issued Pursuant To Litigation Settlement
CommonSharesIssuedPursuantToLitigationSettlement
438000
CY2012 mnkd Common Shares Issuable Pursuant To Litigation Settlement
CommonSharesIssuablePursuantToLitigationSettlement
6056000
CY2012 mnkd Payment By Insurer To Plaintiff
PaymentByInsurerToPlaintiff
800000
CY2012Q1 mnkd Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Increase In Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreaseInGrant
10000000 shares
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
900000
us-gaap Net Income Loss
NetIncomeLoss
-911000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2000
us-gaap Operating Income Loss
OperatingIncomeLoss
-2061265000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1099000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
14219000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4418000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3900000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2267000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
952000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2104918000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1742000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
4220000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
121800000
us-gaap Share Based Compensation
ShareBasedCompensation
137918000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
796393000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
454000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1467573000
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
22260000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
19726000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3331000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1028000
us-gaap Stock Issued1
StockIssued1
2758000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
126777000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
387750000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1596261000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
38825000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-327678000
us-gaap Investment Income Interest
InvestmentIncomeInterest
36996000
us-gaap Income Taxes Paid
IncomeTaxesPaid
26000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
4072000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
15000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
327746000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
61840000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
70000000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
425704000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1667000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
230000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2570000
us-gaap Sales Revenue Net
SalesRevenueNet
3166000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2105294000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1985779000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment For Sale Of Securities Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax
-48000
us-gaap Interest Expense Debt
InterestExpenseDebt
39933000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
796779000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-990000
us-gaap Operating Expenses
OperatingExpenses
2064431000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
35049000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
5248000
us-gaap Interest Paid
InterestPaid
59152000
us-gaap Net Income Loss
NetIncomeLoss
-2104912000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3460000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
207050000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-382000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
151428000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2128124000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1237000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
1397756000
mnkd Accrued Interest On Investments Net Of Amortization Of Discounts
AccruedInterestOnInvestmentsNetOfAmortizationOfDiscounts
191000
mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
212334000
mnkd Collection Of Convertible Preferred Stock Subscriptions Receivable
CollectionOfConvertiblePreferredStockSubscriptionsReceivable
50000000
mnkd Forward Purchase Contract Contribution To Additional Paid In Capital
ForwardPurchaseContractContributionToAdditionalPaidInCapital
29317000
mnkd Issuance Of Convertible Preferred Stock Subscriptions
IssuanceOfConvertiblePreferredStockSubscriptions
50000000
mnkd Issuance Of Put Option By Stockholder
IssuanceOfPutOptionByStockholder
2949000
mnkd Issuance Of Redeemable Convertible Preferred Stock
IssuanceOfRedeemableConvertiblePreferredStock
4296000
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-24253000
mnkd Payment Of Employment Taxes Related To Vested Restricted Stock Units
PaymentOfEmploymentTaxesRelatedToVestedRestrictedStockUnits
13027000
mnkd Increase In Additional Paid In Capital Resulting From Merger
IncreaseInAdditionalPaidInCapitalResultingFromMerger
171154000
mnkd Put Option Redemption By Stockholder
PutOptionRedemptionByStockholder
1921000
mnkd Put Shares Sold To Majority Stockholder
PutSharesSoldToMajorityStockholder
623000
mnkd Reclassification Of Forward Purchase Contract To Additional Paid In Capital
ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital
28080000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-763000
mnkd Stock Expense For Shares Issued Pursuant To Research Agreement
StockExpenseForSharesIssuedPursuantToResearchAgreement
3018000
mnkd Common Shares Issued Pursuant To Litigation Settlement
CommonSharesIssuedPursuantToLitigationSettlement
438000
mnkd Common Shares Issuable Pursuant To Litigation Settlement
CommonSharesIssuablePursuantToLitigationSettlement
6056000
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-41525000
CY2011Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41525000
CY2011Q1 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
121057000 shares
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-44480000
CY2011Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44480000
CY2011Q2 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
121708000 shares
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-38173000
CY2012Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38173000
CY2012Q1 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
143154000 shares
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-36578000
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36578000
CY2012Q2 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
159859000 shares
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-38402000
CY2011Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38402000
CY2011Q3 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
122130000 shares
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-42834000
CY2012Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42834000
CY2012Q3 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
190534000 shares
CY2011Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
-36397000
CY2011Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-36397000
CY2011Q4 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
122357000 shares
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-51781000
CY2012Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-51781000
CY2012Q4 mnkd Basic And Diluted Weighted Average Number Of Shares Outstanding
BasicAndDilutedWeightedAverageNumberOfSharesOutstanding
229234000 shares

Files In Submission

Name View Source Status
0001193125-13-112693-index-headers.html Edgar Link pending
0001193125-13-112693-index.html Edgar Link pending
0001193125-13-112693.txt Edgar Link pending
0001193125-13-112693-xbrl.zip Edgar Link pending
d444376d10k.htm Edgar Link pending
d444376dex1038.htm Edgar Link pending
d444376dex1039.htm Edgar Link pending
d444376dex231.htm Edgar Link pending
d444376dex311.htm Edgar Link pending
d444376dex312.htm Edgar Link pending
d444376dex32.htm Edgar Link pending
d444376dex410.htm Edgar Link pending
d444376dex44.htm Edgar Link pending
d444376dex51.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g444376g13d57.jpg Edgar Link pending
g444376g76p36.jpg Edgar Link pending
g444376g98m47.jpg Edgar Link pending
mnkd-20121231.xml Edgar Link completed
mnkd-20121231.xsd Edgar Link pending
mnkd-20121231_cal.xml Edgar Link unprocessable
mnkd-20121231_def.xml Edgar Link unprocessable
mnkd-20121231_lab.xml Edgar Link unprocessable
mnkd-20121231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending